Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HSBC starts cutting jobs in London office - report

(Sharecast News) - HSBC Holdings has started cutting jobs in London, it was reported on Wednesday, as the blue chip looks to wind down its investment banking offering outside of Asia. New chief executive George Elhedery, who took over from Noel Quinn in September, is radically overhauling the bank's global offering.

As well as cutting $1.5bn from the annual cost base by the end of next year, Elhedery wants London-listed HSBC to refocus on Asia, its most important market. As part of that, the lender is cutting its investment banking and equity capital markets offering in the west. Investment banking accounts for around 6% of HSBC's total revenues.

According to Financial News, citing unnamed people familiar with the matter, the bank has now started informing staff in its London office of job cuts.

The newspaper said that while discussions are ongoing, bankers expect between 200 and 300 front line roles in the London investment bank to go. Further job cuts are also likely in support functions such as legal and compliance.

Some bankers, however, could be offered new positions in the Middle East or Asia, while others will be given the opportunity to stay on temporarily while existing deals are closed out.

HSBC decline to comment on the number of roles at risk.

It told Financial News: "We remain committed to supporting clients globally with our best-in-class debt financing capabilities, leveraging our expertise in debt capital markets and leveraged acquisition finance, complemented by corporate risk solutions and strategic equity and financing, and M&A and ECM in the Middle East and Asia."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.